Intralesional mitoxantrone biopolymer-mediated chemotherapy prolongs survival in rats with experimental brain tumors (Q45033001)

8 December 2017

Intralesional mitoxantrone biopolymer-mediated chemotherapy prolongs survival in rats with experimental brain tumors (English)

1 reference

8 December 2017

1 reference

1 reference

Marco Saini

1

1 reference

8 December 2017

Florian Roser

2

1 reference

8 December 2017

Samii Hussein

3

1 reference

8 December 2017

Madjid Samii

4

1 reference

8 December 2017

Mattia Bellinzona

5

1 reference

8 December 2017

1 July 2004

1 reference

Journal of Neuro-Oncology

8 December 2017

1 reference

8 December 2017

68

1 reference

8 December 2017

225-232

1 reference

8 December 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1023/b:neon.0000033381.96370.6b

8 December 2017

0 references

cites work

Long-term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the antitumor DNA intercalators mAMSA and mitoxantrone

1 reference

12 December 2020

Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.

1 reference

12 December 2020

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

1 reference

12 December 2020

Mitoxantrone-DNA binding and the induction of topoisomerase II associated DNA damage in multi-drug resistant small cell lung cancer cells

1 reference

12 December 2020

First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer

1 reference

12 December 2020

Haemodynamic and Transport Barriers to the Treatment of Solid Tumours

1 reference

12 December 2020

Human central nervous system and plasma pharmacology of mitoxantrone

1 reference

12 December 2020

Mitoxantrone-induced DNA strand breaks in cell-cultures of malignant human astrocytoma and glioblastoma tumors.

1 reference

12 December 2020

Phase II study of high-dose mitoxantrone in the treatment of recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

1 reference

12 December 2020

Effects of 9,10-anthracenedione, 1,4-bis[(2-[(2-hydroxyethyl)amino]-ethyl)amino]-diacetate on cell survival and cell cycle progression in cultured mammalian cells

1 reference

12 December 2020

Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma

1 reference

12 December 2020

Experimental antitumor activity of aminoanthraquinones

1 reference

12 December 2020

The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.

1 reference

12 December 2020

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft

1 reference

12 December 2020

Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

CNS drug design based on principles of blood-brain barrier transport

1 reference

12 December 2020

The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.

1 reference

12 December 2020

Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data

1 reference

12 December 2020

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial

1 reference

12 December 2020

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

1 reference

12 December 2020

Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells

1 reference

12 December 2020

In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

1 reference

12 December 2020

Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay

1 reference

12 December 2020

Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group

1 reference

12 December 2020

Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells

1 reference

12 December 2020

DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides

1 reference

12 December 2020

Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours.

1 reference

12 December 2020

Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics

1 reference

12 December 2020

Chemosensitivity of glioma cells in vitro: a meta analysis.

1 reference

12 December 2020

Polymers for the sustained release of proteins and other macromolecules

1 reference

12 December 2020

Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission

1 reference

12 December 2020

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

12 December 2020

Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

12 December 2020

10.1023/B:NEON.0000033381.96370.6B

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference